Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection
admin To understand the skepticism surrounding Capricor’s current strategy, one must look at the nature of...
Health
Trump Nominates Heidi Overton to Lead the FDA, Positioning a MAHA Architect at the Helm of Drug and Food Regulation.
The selection of Dr. Heidi Overton to serve as the Commissioner of the Food and...
Trump Nominates Heidi Overton to Lead the FDA, Elevating a Key Architect of the MAHA Agenda.
The selection of Dr. Heidi Overton to serve as the Commissioner of the Food and...
STAT News Launches Dedicated Trust-in-Science Desk to Address Growing Misinformation Crisis and Institutional Accountability.
The initiative marks a pivotal evolution for the publication, which was founded more than a...
AstraZeneca Faces Pipeline Pressure After Lung Cancer Trial Failure as U.S. Prescription Drug Prices Hit Historic Lows.
The pharmaceutical landscape on this mid-August Monday presents a stark study in contrasts, balancing the...
Eyepoint study results for vision treatment disappoint, but company still sees promise
Wet age-related macular degeneration remains one of the most lucrative yet challenging frontiers in biotechnology....
Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit
The most jarring news comes from the European continent, where the EMA’s Committee for Medicinal...
Sanofi to lay off 229 workers in Mass., a year after $9.1B Blueprint Medicines acquisition
The layoffs, which are scheduled to begin on October 9 and continue in phases through...
The IRS is probing UnitedHealth, and a private equity slowdown
According to the company’s disclosure, the IRS is specifically scrutinizing transfer pricing and the movement...
Everything the Trump administration did on health care last week
The executive order, signed by President Trump on Monday, seeks to overhaul how the federal...
